2[2]Engineer L,Ahmed AR.Role of intravenous immunoglobalin in the treatment of bullous pemphigoid:analysis of current data[J].J Am Acad Dermatol,2001,44(1):83-88 被引量：1
1Engineer L, Ahmed AR. Role of intravenous immunoglobulin in the treatment of bullous pemphigoid: analysis of current data. J Am Acad Dermatol, 2001 , 44:83 - 88. 被引量：1
2Mouthon L, Kaveri SV, Spalter SH, et al. Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol, 1996, 104:3-9. 被引量：1
3Spuls PI, Brakman M, Westerhof W, et al. Treatment of generalized bullous pemphigoid with topical corticosteroids. Acta Derm Venereol,1995, 75:89. 被引量：1
4Joly P, Roujeau JC, Benichou J, et al. A comparison of oral and topicat corticosteroids in patients with bullous pemphigoid. N Engl J Med,2002, 346:321 - 327. 被引量：1
5Fivenson DP, Breneman DL, Rosen GB, et al. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol, 1994, 130:753 - 758. 被引量：1
6Loo WJ, Kirtschig G, Wojnarowska F. Minocycline as a therapeutic option in bullous pemphigoid. Clin Exp Dermatol, 2001, 26:376. 被引量：1
7Yancey KB, Egan CA. Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. JAMA, 2000, 284:350 -356. 被引量：1
8Lebrun-Vignes B, Roujeau JC, Bernard P, et al. Prednisone is more effective than prednisolone metasulfobenzoate in the treatment of bullous pemphigoid. Arch Dermatol, 1999, 135:89-90. 被引量：1
9Egan CA, Meadows KP, Zone JJ. Plasmapheresis as a steroid saving procedure in bullous pemphigoid. Int J Dematol, 2000, 39:230 -235. 被引量：1
10Bohm M, Beissert S, Schwarz T, et al. Bullous pemphigoid treated with mycophenolate mofetil. Lancet, 1997, 349:541. 被引量：1
9Wojnarowska F,Kirtschig G,Highet AS,et al.Guidelines for the management of bullous pemphigoid.Br J Dermatol,2002,147(2):214-221. 被引量：1
10Engineer L,Ahmed AR.Role of intravenous immunoglobulin in the treatment of bullous pemphigoid:analysis of current data.J Am Acad Dermatol,2001,44(1):83-88. 被引量：1
